Logo image
Placental Membrane Provides Improved Healing Efficacy and Lower Cost Versus a Tissue-Engineered Human Skin in the Treatment of Diabetic Foot Ulcerations
Journal article   Open access   Peer reviewed

Placental Membrane Provides Improved Healing Efficacy and Lower Cost Versus a Tissue-Engineered Human Skin in the Treatment of Diabetic Foot Ulcerations

Paul Glat, Dennis P. Orgill, Robert Galiano, David Armstrong, Thomas Serena, Lawrence A. DiDomenico, Jarrod Kaufman, Marissa J. Carter, Alan M. Jacobs and Charles M. Zelen
Plastic and reconstructive surgery. Global open, v 7(8), pp e2371-e2371
30 Aug 2019
PMID: 31592387
url
https://doi.org/10.1097/gox.0000000000002371View
Published, Version of Record (VoR)CC BY-NC-ND V4.0 Open
url
https://doi.org/10.1097/GOX.0000000000002371View
Published, Version of Record (VoR) Open

Abstract

Original
Supplemental Digital Content is available in the text. Aseptically processed dehydrated human amnion and chorion allograft (dHACA) (AmnioBand) has shown great promise in the treatment of recalcitrant diabetic foot ulcers (DFUs) when compared with standard wound care but has not yet been compared to any other tissue forms used in treating DFUs. The hypothesis was to conduct a randomized controlled trial in which dHACA was compared to one of the earliest and most commonly accepted tissue-engineered skin substitutes (TESS) (Apligraf) in the treatment of nonhealing DFUs over a period of 12 weeks to assess the superiority of healing.

Metrics

13 Record Views
31 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Surgery
Logo image